Advanced Biomed (ADVB) Stock: Buy, Sell, or Hold?
ADVB - Advanced Biomed Inc. Common Stock
$8.19
-0.66 (-7.46%)
βΌ
5d:
-12.87%
30d:
+7.76%
90d:
+104.24%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: May 21, 2026
0d
Get Alerted When ADVB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
βΈοΈ WAIT FOR STABILIZATION: ADVB is down 12.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
βΈοΈ WAIT FOR STABILIZATION: ADVB is down 12.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: ADVB is currently trading at $8.19, which is considered slightly low relative to its 30-day fair value range of $7.76 to $9.48.
Technical Outlook: Technically, ADVB is in a uptrend. Immediate support is located at $7.90, while resistance sits at $10.80. Short-term momentum is weak, with the stock down 7.5% recently.
Market Sentiment: ADVB scores 32/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ADVB is in a uptrend. Immediate support is located at $7.90, while resistance sits at $10.80. Short-term momentum is weak, with the stock down 7.5% recently.
Market Sentiment: ADVB scores 32/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$7.76 -
$9.48
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
47.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (32/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-7.5%)
- WARNING: Composite score 45/100 in the bottom quintile β this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$7.76 -
$9.48
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$7.90
Resistance Level
$10.80
Current Trend
Uptrend
Technical data as of
Sep 11, 2026
Fundamental Context
Share & Embed Analysis
Last updated: September 13, 2026 9:31 AM ET
Data refreshes hourly during market hours. Next update: 10:31 AM
Data refreshes hourly during market hours. Next update: 10:31 AM
π₯ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ADVB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific⦠|
STRONG BUY
31 analysts |
$645 | 51 HOLD |
|
EXAS
EXACT Sciences Corporati⦠|
STRONG BUY
26 analysts |
$106 | 52 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$229 | 49 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$196 | 49 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$344 | 47 HOLD |